Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F H Igney

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Ernst Schering Research Foundation Workshop|November 6, 2004
Acute and chronic models of allergic contact dermatitis: advantages and limitationsT M Zollner, F H Igney, K Asadullah
European Journal of Immunology|March 31, 2000
Tumor counterattack--concept and realityF H Igney, C K Behrens, P H Krammer
Journal of Immunology (Baltimore, Md. : 1950)|February 24, 2001
CD95 ligand-expressing tumors are rejected in anti-tumor TCR transgenic perforin knockout miceC K Behrens, F H Igney, B Arnold, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Ernst Schering Research Foundation Workshop|November 6, 2004
Acute and chronic models of allergic contact dermatitis: advantages and limitationsT M Zollner, F H Igney, K Asadullah
European Journal of Immunology|March 31, 2000
Tumor counterattack--concept and realityF H Igney, C K Behrens, P H Krammer
Journal of Immunology (Baltimore, Md. : 1950)|February 24, 2001
CD95 ligand-expressing tumors are rejected in anti-tumor TCR transgenic perforin knockout miceC K Behrens, F H Igney, B Arnold, et al.
Pageof 1